At ELRIG’s 2025 meeting in GSK’s Stevenage campus, Recursion’s Executive Director of Computational Biology, Dr. Kelly ...
Drug Optimization and Repurposing (53.7% market share in 2023) AI excels in identifying new uses for existing drugs and refining molecular structures to improve efficacy and reduce side effects—an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback